Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nancy Ratner

Showing results (101-110 of 147) with videos related to

Pageof 15
Sort By:
Biorxiv : the Preprint Server for Biology|April 8, 2024
Pharmacogenomic synthetic lethal screens reveal hidden vulnerabilities and new therapeutic approaches for treatment of NF1-associated tumorsKyle B Williams, Alex T Larsson, Bryant J Keller, et al.
The American Journal of Pathology|May 17, 2014
Trp53 haploinsufficiency modifies EGFR-driven peripheral nerve sheath tumorigenesisEric P Rahrmann, Branden S Moriarity, George M Otto, et al.
The Journal of Clinical Investigation|December 18, 2003
Neurofibromin-deficient Schwann cells secrete a potent migratory stimulus for Nf1+/- mast cellsFeng-Chun Yang, David A Ingram, Shi Chen, et al.
Journal of the National Cancer Institute|November 9, 2017
Neurofibromatosis Type 1-Associated MPNST State of the Science: Outlining a Research Agenda for the FutureKarlyne M Reilly, AeRang Kim, Jaishri Blakely, et al.
American Journal of Medical Genetics. Part A|January 19, 2010
What's new in neurofibromatosis? Proceedings from the 2009 NF Conference: new frontiersJoseph L Kissil, Jaishri O Blakeley, Rosalie E Ferner, et al.
Molecular Cancer Therapeutics|October 2, 2025
Pharmacogenomic synthetic lethal screens reveal hidden vulnerabilities and new therapeutic approaches for treatment of NF1-associated tumorsKyle B Williams, Alex T Larsson, Bryant J Keller, et al.
Scientific Reports|December 25, 2019
Prevalence of the Hippo Effectors YAP1/TAZ in Tumors of Soft Tissue and BoneIlka Isfort, Sandra Elges, Magdalene Cyra, et al.
Nature Communications|October 25, 2018
Defective transcription elongation in a subset of cancers confers immunotherapy resistanceVishnu Modur, Navneet Singh, Vakul Mohanty, et al.
Plos One|May 21, 2019
The evolution and multi-molecular properties of NF1 cutaneous neurofibromas originating from C-fiber sensory endings and terminal Schwann cells at normal sites of sensory terminations in the skinFrank L Rice, George Houk, James P Wymer, et al.
Nature Genetics|May 21, 2013
Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and pathways driving tumorigenesisEric P Rahrmann, Adrienne L Watson, Vincent W Keng, et al.
Pageof 15

Showing results (101-110 of 147) with videos related to

Sort By:
Pageof 15
Biorxiv : the Preprint Server for Biology|April 8, 2024
Pharmacogenomic synthetic lethal screens reveal hidden vulnerabilities and new therapeutic approaches for treatment of NF1-associated tumorsKyle B Williams, Alex T Larsson, Bryant J Keller, et al.
The American Journal of Pathology|May 17, 2014
Trp53 haploinsufficiency modifies EGFR-driven peripheral nerve sheath tumorigenesisEric P Rahrmann, Branden S Moriarity, George M Otto, et al.
The Journal of Clinical Investigation|December 18, 2003
Neurofibromin-deficient Schwann cells secrete a potent migratory stimulus for Nf1+/- mast cellsFeng-Chun Yang, David A Ingram, Shi Chen, et al.
Journal of the National Cancer Institute|November 9, 2017
Neurofibromatosis Type 1-Associated MPNST State of the Science: Outlining a Research Agenda for the FutureKarlyne M Reilly, AeRang Kim, Jaishri Blakely, et al.
American Journal of Medical Genetics. Part A|January 19, 2010
What's new in neurofibromatosis? Proceedings from the 2009 NF Conference: new frontiersJoseph L Kissil, Jaishri O Blakeley, Rosalie E Ferner, et al.
Molecular Cancer Therapeutics|October 2, 2025
Pharmacogenomic synthetic lethal screens reveal hidden vulnerabilities and new therapeutic approaches for treatment of NF1-associated tumorsKyle B Williams, Alex T Larsson, Bryant J Keller, et al.
Scientific Reports|December 25, 2019
Prevalence of the Hippo Effectors YAP1/TAZ in Tumors of Soft Tissue and BoneIlka Isfort, Sandra Elges, Magdalene Cyra, et al.
Nature Communications|October 25, 2018
Defective transcription elongation in a subset of cancers confers immunotherapy resistanceVishnu Modur, Navneet Singh, Vakul Mohanty, et al.
Plos One|May 21, 2019
The evolution and multi-molecular properties of NF1 cutaneous neurofibromas originating from C-fiber sensory endings and terminal Schwann cells at normal sites of sensory terminations in the skinFrank L Rice, George Houk, James P Wymer, et al.
Nature Genetics|May 21, 2013
Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and pathways driving tumorigenesisEric P Rahrmann, Adrienne L Watson, Vincent W Keng, et al.
Pageof 15